This suggested a positive correlation between RSK4 isoform expression and the relative proportion of B cells, CD4+ T cells, and CD8+ T cells (p < 0.05) among cancer types where high isoform 1 or 2 expression associates with better survival (LGG and KIRC). This evidence concerns the gene RPS6KA6 and cancer.